ASP Isotopes Inc.
PublicASP Isotopes Inc. is now publicly traded
The data on this page reflects ASP Isotopes Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series B
Jul 15, 2026
Total Funding Raised
$114.18M
Company Overview
ASP Isotopes Inc. operates in Basic Materials and is based in the United States. It has raised $114.18M.
ASP Isotopes Inc. is a specialty chemicals company that develops a differentiated isotope enrichment platform to produce critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy.
Sector
Basic Materials
AI Layer
Non-AI
ASP Isotopes Inc. Comparables
Compare ASP Isotopes Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fluxnium | 46% | |
| Nucleon Energy Inc. | 34% |
For institutional investors. Book with your work email.
ASP Isotopes Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 15, 2026 | ||||
| Private Placement | Mar 17, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ASP Isotopes Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.